Last 4.14 INR
Change Today -0.07 / -1.66%
Volume 6.6K
SARA On Other Exchanges
Symbol
Exchange
Mumbai
As of 5:14 AM 01/23/15 All times are local (Market data is delayed by at least 15 minutes).

ambalal sarabhai ent ltd (SARA) Snapshot

Open
4.10
Previous Close
4.21
Day High
4.30
Day Low
4.10
52 Week High
09/16/14 - 7.21
52 Week Low
04/7/14 - 2.26
Market Cap
317.6M
Average Volume 10 Days
8.3K
EPS TTM
-2.25
Shares Outstanding
76.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for AMBALAL SARABHAI ENT LTD (SARA)

Related News

No related news articles were found.

ambalal sarabhai ent ltd (SARA) Related Businessweek News

No Related Businessweek News Found

ambalal sarabhai ent ltd (SARA) Details

Ambalal Sarabhai Enterprises Limited, together with its subsidiaries, manufactures, sells, and deals in pharmaceuticals in India. It operates through Pharmaceuticals and Electronics & Broadcast Equipments segments. The company offers drug and pharmaceutical formulations in the form of injectables, liquids, ointments, powders, tablets, capsules, and others, as well as supplies finished dosage forms and active pharmaceutical ingredients. It also provides electronic instruments and services. In addition, the company exports its pharmaceutical products. Ambalal Sarabhai Enterprises Limited markets its pharmaceutical products through distributors and generic channels. The company was incorporated in 1978 and is based in Vadodara, India.

Founded in 1978

ambalal sarabhai ent ltd (SARA) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

ambalal sarabhai ent ltd (SARA) Key Developments

Ambalal Sarabhai Enterprises Ltd. Reports Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2014

Ambalal Sarabhai Enterprises Ltd. reported unaudited standalone earnings results for the second quarter and six months ended September 30, 2014. For the quarter, the company reported net sales/income from operations was INR 42.251 million against INR 39.627 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 37.786 million against INR 37.534 million a year ago. Loss from ordinary activities before tax was INR 62.917 million against INR 54.113 million a year ago. Net loss for the period was INR 62.917 million or INR 0.82 basic and diluted per share (of INR 10 each) (not annualized) against INR 54.113 million or INR 0.71 basic and diluted per share (of INR 10 each) (not annualized) a year ago. For the six-month period, the company reported net sales/income from operations was INR 84.836 million against INR 74.840 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 77.484 million against INR 77.788 million a year ago. Loss from ordinary activities before tax was INR 128.567 million against INR 105.252 million a year ago. Net loss for the period was INR 128.567 million or INR 1.68 basic and diluted per share (of INR 10 each) (not annualized) against INR 105.252 million or INR 1.37 basic and diluted per share (of INR 10 each) (not annualized) a year ago.

Ambalal Sarabhai Enterprises Ltd., Board Meeting, Nov 14, 2014

Ambalal Sarabhai Enterprises Ltd., Board Meeting, Nov 14, 2014.

Ambalal Sarabhai Enterprises Ltd. Reports Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2014

Ambalal Sarabhai Enterprises Ltd. reported unaudited standalone earnings results for the first quarter ended June 30, 2014. For the quarter, the company reported net sales/income from operations (net of excise duty) was INR 42.585 million against INR 35.213 million a year ago. Loss from operations before other income, finance costs and exceptional items was INR 39.698 million against INR 40.254 million a year ago. Loss from ordinary activities before tax was INR 65.650 million against INR 51.139 million a year ago. Net loss was INR 65.650 million or INR 0.86 basic and diluted per share (of INR 10 each) (not annualized) against INR 51.139 million or INR 0.67 basic and diluted per share (of INR 10 each) (not annualized) a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SARA:IN 4.14 INR 0.00

SARA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SARA.
View Industry Companies
 

Industry Analysis

SARA

Industry Average

Valuation SARA Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMBALAL SARABHAI ENT LTD, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.